Get the Stockscreener App
76.13
1.94%
-1.51
After Hours:
76.13
Henry Schein Inc stock is traded at $76.13, with a volume of 1.92M.
It is down -1.94% in the last 24 hours and down -0.55% over the past month.
Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.
See More
Previous Close:
$77.64
Open:
$75.71
24h Volume:
1.92M
Relative Volume:
1.38
Market Cap:
$8.96B
Revenue:
$12.50B
Net Income/Loss:
$314.00M
P/E Ratio:
31.20
EPS:
2.44
Net Cash Flow:
$421.00M
1W Performance:
-3.07%
1M Performance:
-0.55%
6M Performance:
+3.69%
1Y Performance:
+9.27%
1-Day Range:
$74.07
$76.81
1-Week Range:
$74.07
$80.03
52-Week Range:
$60.56
$82.49
Henry Schein Inc Stock (HSIC) Company Profile
Name
Henry Schein Inc
Sector
Industry
Phone
(631) 843-5500
Address
135 DURYEA RD, MELVILLE, NY
Compare HSIC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
76.13 | 9.14B | 12.50B | 314.00M | 421.00M | 2.44 |
|
MCK
Mckesson Corporation
|
825.62 | 100.72B | 387.09B | 4.23B | 6.01B | 32.12 |
|
COR
Cencora Inc
|
342.16 | 65.12B | 321.33B | 1.57B | 3.21B | 7.9518 |
|
CAH
Cardinal Health Inc
|
202.52 | 47.78B | 234.31B | 1.61B | 4.45B | 6.6243 |
|
AHG
Akso Health Group Adr
|
1.54 | 757.90M | 2.22M | -5.63M | -1.68M | -0.24 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Overweight |
| Aug-26-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Jul-25-25 | Downgrade | Stifel | Buy → Hold |
| Jul-14-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Feb-14-25 | Initiated | Wells Fargo | Equal Weight |
| Jan-06-25 | Upgrade | BofA Securities | Underperform → Buy |
| Dec-04-24 | Initiated | Mizuho | Neutral |
| Jul-22-24 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-12-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-10-23 | Upgrade | Stifel | Hold → Buy |
| Aug-08-22 | Upgrade | UBS | Sell → Neutral |
| Jul-21-22 | Downgrade | Goldman | Buy → Neutral |
| Jun-14-22 | Downgrade | Robert W. Baird | Outperform → Neutral |
| May-13-22 | Resumed | Credit Suisse | Outperform |
| Jan-31-22 | Initiated | Morgan Stanley | Underweight |
| Jan-07-22 | Upgrade | Credit Suisse | Neutral → Outperform |
| Oct-01-21 | Resumed | Credit Suisse | Neutral |
| Feb-08-21 | Resumed | Piper Sandler | Overweight |
| Jan-04-21 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Nov-03-20 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| May-06-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Apr-07-20 | Upgrade | Goldman | Neutral → Buy |
| Apr-02-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jan-09-20 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Jan-02-20 | Upgrade | Evercore ISI | Underperform → In-line |
| Aug-07-19 | Downgrade | William Blair | Outperform → Mkt Perform |
| May-30-19 | Initiated | Wolfe Research | Underperform |
| May-15-19 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Apr-18-19 | Initiated | Guggenheim | Buy |
| Jan-17-19 | Initiated | UBS | Sell |
| Jan-03-19 | Downgrade | Evercore ISI | In-line → Underperform |
| Jan-02-19 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Nov-08-18 | Reiterated | Barrington Research | Outperform |
| Oct-25-18 | Downgrade | Edward Jones | Hold → Sell |
| Oct-19-18 | Resumed | Goldman | Neutral |
| Oct-04-18 | Reiterated | Robert W. Baird | Outperform |
| Aug-07-18 | Reiterated | Stifel | Hold |
| Apr-24-18 | Downgrade | Goldman | Buy → Neutral |
| Apr-04-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
View All
Henry Schein Inc Stock (HSIC) Latest News
Henry Schein names Frederick M. Lowery as new CEO - Newsday
Henry Schein Appoints Frederick M Lowery as New CEO - Orthodontic Products
Henry Schein, Inc. Announces Management Changes - marketscreener.com
Henry Schein, Inc. Appoints Frederick M. Lowery as Chief Executive Officer, Effective March 2, 2026 - marketscreener.com
Henry Schein names Frederick Lowery as new CEO - Long Island Business News
Henry Schein appoints industry veteran Frederick M. Lowery as new CEO - Oral Health Group
Henry Schein names new CEO - HME News
Henry Schein, Inc. (HSIC) Announces New CEO Appointment - GuruFocus
Henry Schein picks new CEO with significant healthcare distribution experience - MassDevice
Henry Schein (HSIC) Appoints Frederick Lowery as New CEO - GuruFocus
Henry Schein Names Frederick Lowery Chief Executive - marketscreener.com
Henry Schein appoints new CEO amid governance changes - TipRanks
Frederick Lowery named new CEO of Henry Schein, effective March 2026 - Investing.com Australia
Henry Schein Appoints Frederick M. Lowery as Chief Executive Officer - citybiz
Henry Schein Names Frederick M. Lowery as Chief Executive Officer - The Joplin Globe
Henry Schein Stock Tests Investor Patience As Healthcare Distribution Re?rates - AD HOC NEWS
Can Henry Schein Inc. stock maintain growth trajectoryQuarterly Portfolio Review & Fast Gain Stock Trading Tips - ulpravda.ru
Henry Schein (HSIC) Q1 Earnings Beat Estimates - sharewise.com
Is Henry Schein (HSIC) Pricing Look Attractive After Recent 4.5% Weekly Gain - simplywall.st
Will Henry Schein Inc. stock split attract more investorsWeekly Gains Summary & Real-Time Chart Pattern Alerts - ulpravda.ru
Is Henry Schein Inc. stock a safe investment in uncertain markets2025 Trade Ideas & Daily Chart Pattern Signal Reports - ulpravda.ru
Is Henry Schein Inc. stock a bargain at current levels2025 Market Sentiment & Risk Managed Investment Signals - ulpravda.ru
Bank of America Securities Reaffirms Their Buy Rating on Henry Schein (HSIC) - The Globe and Mail
The Truth About Henry Schein Inc: Is This ‘Boring’ Stock Secretly a Power Play? - AD HOC NEWS
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
Henry Schein’s Stock Under Pressure: Is Wall Street Turning Too Pessimistic on SCHE? - AD HOC NEWS
The Truth About Henry Schein Inc: Quiet Dental Giant Or Sleeper Stock You’re Sleeping On? - AD HOC NEWS
New Henry Schein CEO expected by mid-January as Bergman extends tenure - MedTech Dive
Aug Technicals: Is Henry Schein Inc stock a bargain at current levels2025 Bull vs Bear & Verified Short-Term Trading Plans - moha.gov.vn
Can Henry Schein Inc stock surprise with earnings upsideInflation Watch & Verified Swing Trading Watchlists - moha.gov.vn
Dow Update: What technical signals suggest for Henry Schein Inc stockBear Alert & Daily Profit Maximizing Trade Tips - moha.gov.vn
List of 35 Acquisitions by Henry Schein (Jan 2026) - Tracxn
Henry Schein Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Earnings Beat: Why Henry Schein Inc. stock remains undervalued2025 Pullback Review & Weekly High Potential Stock Alerts - moha.gov.vn
Why Henry Schein, Inc. (NASDAQ:HSIC) Could Be Worth Watching - 富途牛牛
Henry Schein (NASDAQ:HSIC) Has More To Do To Multiply In Value Going Forward - Yahoo Finance
One Fund Bought Up Henry Schein Stock Amid Record Quarterly Results and a New $200 Million Efficiency Plan - AOL.com
Henry Schein to announce next CEO by mid-January - MassDevice
Interview: Brian Weatherly, CEO of Henry Schein One - Adam Mendler
One Fund Bought Up Henry Schein Stock Amid Record Quarterly Results and a New $200 Million Efficiency Plan - The Motley Fool
Henry Schein Joins J.P. Morgan Healthcare Event - Dentistry Today
Henry Schein to Participate in the J.P. Morgan Conference in January - Business Wire
Marathon Asset Management Ltd Cuts Stock Position in Henry Schein, Inc. $HSIC - MarketBeat
Henry Schein Earnings Notes - Trefis
Henry Schein, Inc. (NASDAQ:HSIC) Receives Average Recommendation of "Hold" from Analysts - MarketBeat
Henry Schein expects to appoint next CEO by mid-January - MSN
Henry Schein, Inc. $HSIC Shares Purchased by Swedbank AB - MarketBeat
Assenagon Asset Management S.A. Decreases Stock Position in Henry Schein, Inc. $HSIC - MarketBeat
Henry Schein Board Advances CEO Succession and Transition - The Globe and Mail
Henry Schein extends private placement facilities to 2028 - MSN
How is Henry Schein's stock performance compared to other healthcare stocks? - MSN
Henry Schein Inc Stock (HSIC) Financials Data
Revenue
Net Income
Cash Flow
EPS
11.59%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):